ask="N/A"
ask_size="N/A"
average_daily_volume="357050"
bid="29.00"
bid_size="200"
book_value="3.58"
change="+1.52"
change_from_200_day_moving_average="6.17"
change_from_50_day_moving_average="3.20"
change_from_52_week_high="-2.46"
change_From_52_week_low="22.60"
change_in_percent="+4.43%"
close="35.87"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.46"
ebitda="-65.10M"
eps_estimate_current_year="-2.74"
eps_estimate_next_quarter="-0.79"
eps_estimate_next_year="-4.07"
ex_dividend_date="N/A"
float_shares="18345000"
high="37.55"
high_52_weeks="38.33"
last_trade_date="2/15/2017"
last_trade_price="35.87"
last_trade_size="12298"
last_trade_time="4:00pm"
low="34.90"
low_52_weeks="13.27"
market_capitalization="979.00M"
moving_average_200_day="29.70"
moving_average_50_day="32.67"
name="Blueprint Medicines Corporation"
notes="N/A"
one_year_target_price="37.33"
open="34.92"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+20.77%"
percent_change_from_50_day_moving_average="+9.80%"
percent_change_from_52_week_high="-6.42%"
percent_change_from_52_week_low="+170.31%"
previous_close="34.35"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="9.59"
price_per_sales="37.93"
revenue="24.72M"
shares_outstanding="27293000"
short_ratio="8.24"
stock_exchange="NMS"
symbol="BPMC"
volume="342310"
weeks_range_52="13.27 - 38.33"
